INR:1605. satta king 70 Takeda Pharmaceuticals' Vedolizumab is close to approval for the treatment of ulcerative colitis and Crohn's disease Traditional Chinese med ...
Welcome to the Lancet Global Burden of Disease (GBD) Resource Centre, bringing together the most comprehensive data and analysis of worldwide trends in global health, published across the Lancet ...